Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development
2025 · PLoS ONE · 5 citations
https://doi.org/10.1371/journal.pone.0312957